VectivBio Holding AG
VECT · NASDAQ
12/31/2022 | 6/30/2022 | 12/31/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.06 | 0.10 | 0.00 | -0.07 |
| FCF Yield | 14.16% | -46.36% | -27.27% | -11.48% |
| EV / EBITDA | -5.98 | -1.88 | -0.69 | -3.91 |
| Quality | ||||
| ROIC | -12.50% | -35.69% | -36.37% | -30.28% |
| Gross Margin | 100.00% | 100.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | -1.90 | 1.69 | 0.83 | 0.83 |
| Growth | ||||
| Revenue 3-Year CAGR | 3,012,476.83% | 2,987,440.92% | -100.00% | -100.00% |
| Free Cash Flow Growth | 149.01% | -206.06% | 0.00% | -88.48% |
| Safety | ||||
| Net Debt / EBITDA | 7.37 | 2.77 | 2.36 | 3.33 |
| Interest Coverage | 1,057.53 | -16.29 | -2,414.14 | -2,414.14 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 190.38 | 4.07 | 0.00 | 0.00 |